ALNY News
Alnylam Pharmaceuticals, Inc.
$159.37
-$0.48(-0.30%)
29
Overall
20
Value
18
Tech
50
Quality
Market Cap
$21.35B
Volume
1.66M
52W Range
$154.30 - $479.79
Target Price
$312.23
ALNY news: the latest Alnylam Pharmaceuticals, Inc. headlines, press releases and market updates, newest first.
Latest ALNY News
- Piper Sandler Sticks to Its Buy Rating for Alnylam Pharma (ALNY)TipRanks Auto-Generated Intelligence Newsdesk · Nov 10, 2026
- Cantor Fitzgerald Remains a Hold on Alnylam Pharma (ALNY)TipRanks Auto-Generated Intelligence Newsdesk · Nov 6, 2026
- Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT), Alnylam Pharma (ALNY) and Illumina (ILMN)TipRanks Newsroom · Oct 30, 2026
- Alnylam Pharma (ALNY) Receives a Hold from GuggenheimTipRanks Auto-Generated Intelligence Newsdesk · Oct 28, 2026
- Analysts Offer Insights on Healthcare Companies: Cogent Biosciences (COGT), Merck & Company (MRK) and Alnylam Pharma (ALNY)TipRanks Newsroom · Oct 27, 2026
- Analysts Conflicted on These Healthcare Names: Roivant Sciences (ROIV), Alnylam Pharma (ALNY) and Haemonetics (HAE)TipRanks Newsroom · Oct 21, 2026
- Alnylam Pharma (ALNY) Receives a New Rating from a Top AnalystTipRanks Auto-Generated Intelligence Newsdesk · Oct 14, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALNY | $159.37 | -0.3% | 1.66M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Alnylam Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW